Shire announced that the European Commission granted Marketing Authorisation for once-daily, non-stimulant Intuniv (guanfacine hydrochloride prolonged release tablets) for the...
Shire plc announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the...